Evidence map›Paper›PMID 33549520›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2021

First and second wave of SARS-CoV2 in Italian Cystic Fibrosis patients: Data from Italian Cystic Fibrosis Registry.

Rita Padoan, V Carnovale, D Salvatore, S Quattrucci, D Taruscio, G Floridia, A Amato, Gianluca Ferrari, Giuseppe Campagna, Marco Salvatore

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Distinct Responses of Cystic Fibrosis Epithelial Cells to SARS-CoV-2 and Influenza A Virus.American journal of respiratory cell and molecular biology · 2025
    Article
  2. Review
  3. Article
  4. The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rita PadoanCystic Fibrosis Support Center, Department of Paediatric, University of Brescia. Electronic address: ritaf54@gmail.com.
V CarnovaleDepartment of Translational Medical Science, Cystic Fibrosis Center, Adult Unit, University of Naples "Federico II", Italy.
D SalvatoreCystic Fibrosis Center, Hospital San Carlo, Potenza, Italy.
S QuattrucciItalian Cystic Fibrosis Ligue.
D TaruscioNational Center Rare Diseases, Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, Rome, Italy.
G FloridiaPre-BIO-Bioetic Unit, Istituto Superiore di Sanità, Rome, Italy.
A AmatoItalian Cystic Fibrosis Ligue.
Gianluca FerrariItalian Cystic Fibrosis Ligue.
Giuseppe CampagnaItalian Cystic Fibrosis Ligue; Department of Clinical and Molecular Medicine, University of Rome La Sapienza.
Marco SalvatoreNational Center Rare Diseases, Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Cystic FibrosisHumansItalyPandemicsRegistriesSARS-CoV-2

Identifiers

PMID33549520
PMCPMC7835102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.